UnknownNot Applicable

Arterial Calcification in the Diabetes

France169 participantsStarted 2014-02

Plain-language summary

The blood concentration of the protein RANKL could be predictive of the calcification of the leg arteries, which is a major complication occurring during diabetes. The objective of the DIACART study is to show that blood RANKL concentration predict the progression of calcification of the leg arteries in diabetic patients, independently of other cardiovascular risk factors.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * type 2 diabetes * women over 60 * men over 50 years * men and women with known coronary artery disease Non-Exclusion criteria: * severe renal failure * immunodeficiency * acute infectious or inflammatory disease * history of bypass surgery or sub-popliteal angioplasty

What they're measuring

Serum RANKL concentrations

Timeframe: Baseline

Trial details

NCT IDNCT02431234

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-02

View on ClinicalTrials.gov More Diabetic Vascular Diseases trials